LOGO DEMCON_life science health_diap
  • Services
  • Markets
    • critical care
    • treatment
    • diagnostic & monitoring
    • wearables & implantables
    • in-vitro diagnostics
    • biotech
  • expertise
    • systems engineering
    • electronics & electrical
    • QA/RA engineering
    • software & data science
    • optics & vision
    • manufacturing
    • human centered design
    • mechanics
    • mechatronics
  • Showcases
  • About us
  • CONTACT
  • career
  • news
  • events
expertises-MechanicalEngineering
  1. Home›
  2. showcases›
  3. bridging the multi-engineering gap from radionuclide production to patient.

bridging the multi-engineering gap from radionuclide production to patient.

Novel radionuclides such as 68Ga, 212Pb, 225Ac, 177Lu aim to advance diagnostics and therapy through shorter decay times, increased efficacy and targeted applications. Meanwhile, existing radionuclides such as 99mTc, 18F are still used for majority of diagnostic procedures. Meeting market demand for novel and existing radionuclides remains challenging and necessitates new modes of production (accelerator/cyclotron), and new harvesting techniques (novel radionuclide generators).

highlights

  • Novel radionuclides boost diagnostics and therapy.
  • Production demands call for new methods.
  • Accelerator facilities face complex challenges.
  • Efficient harvesting ensures purity and safety.
  • Multi-disciplinary design speeds up solutions.

challenges in every step of the supply chain.

Designing systems and processes that allow radionuclides to reach patients poses challenges in every step of the supply chain: production, followed by distribution and harvesting, and end-delivery to the patient. Meeting requirements for radiation protection, component radiation resistance, and compliance to good manufacturing practice (GMP) are essential at each step.

tailor made devices and tooling for production and delivery.

For production, the core requirement is to generate high specific activity. For new accelerator facilities, the engineering challenges magnify enormously in scale and time, due to the high intensity of irradiation. Some of the drivers for complexity are beam induced heating, radiation damage, and radioactive waste production and decommissioning. For new harvesting technologies, the core requirement is to efficiently separate pure daughter isotopes, that can be timely labeled and transported to the end users. Unique isotope decay modes call for tailor-made systems that are compliant with radiation exposure limits.

expertises-Manufacturing
mechanical engineering

multi-engineering design approach.

To solve the challenges for a variety of production systems, we work with a combination of engineering disciplines such as nuclear and radiation physics, mechanical engineering, thermal engineering, quality assurance, robotics, automation and systems engineering. By ensuring alignment among all disciplines, the biggest risks are identified and mitigations are proposed early on in the design process. This results in fast design iteration that covers the entire requirement space. Thus, the final engineering solutions are comprehensive, yet obtained efficiently.

the results.

The above design approach is used to develop various radionuclide production systems. For example in the SMART project, where the above discussed challenges pushed the limits of technological feasibility. This multi-engineering design approach led to important choices for the cooling concept, modularity and shielding design. These choices were verified in successful feasibility tests.

more about the SMART-project
Mechanics-advanced DFP solutions

"what about a multi-engineering approach?"

New routes of radionuclide production are challenging, but a multi-engineering approach can help achieve comprehensive solutions for all steps in the supply chain, thus bringing the novel radionuclides successfully to the patient.

Jan-Willem Doosje

Jan-Willem Doosje

+31 (0)6 27 08 73 13
CONTACT US

explore more cases.

023IMG_3526-1023IMG_3526-1

a robotic system for MR-guided needle insertion.

We developed an MRI-compatible Needle Positioning System for precise biopsies in suspected prostate cancer cases. Discover how we support early diagnosis.

Read more
Handscan_foto oma_1Handscan_foto oma_1

fast, painless and objective screening for rheumatoid arthritis.

We developed the Hemicsto objectively monitor inflammatory activity, supporting diagnoses and fine-tuning treatments. Discover how it enhances care!

Read more
DSC07557-1DSC07557-1

swift development of ultra-fast PCR Covid-19 test system

We successfully brought the reader from concept to functional device within a tight schedule. Learn how we meet deadlines with precision and efficiency!.

Read more
Thumbnail_showcase_sEMGThumbnail_showcase_sEMG

closed-circuit gas mixing platform for therapeutic treatment.

We developed a gas mixing platform that blends therapeutic gas into an air/O2 mixture for patient treatment. Learn more about this innovative solution.

Read more
BACK TO ALL SHOWCASES
LOGO DEMCON_life science health_diap
ServicesMarketsExpertiseShowcasesAbout us

lsh@demcon.com

+31 88 115 20 00

contact us
Demcon life sciences & health is part of the Demcon group
cookie policyprivacy statement
© 2025 Demcon. All rights reserved.